AARON MARK HOPKINS
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology FORT WORTH, TX NPI 1699237693
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology TX ABIOMED All categories
General Payments — all program years on this page
$408.59
- Category: General Payments
- Program years: PY2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $408.59 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.59 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $337.07 | 5 |
| Acerta Pharma LLC | $22.55 | 1 |
| OPKO Pharmaceuticals, LLC | $18.87 | 1 |
| Aurinia Pharma U.S., Inc. | $16.34 | 1 |
| Nevro Corp. | $13.76 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $408.59 | 9 |
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104446585 | AstraZeneca Pharmaceuticals LP | $22.55 | 12/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1112845410 | OPKO Pharmaceuticals, LLC | $18.87 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130767700 | Nevro Corp. | $13.76 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142309425 | ABIOMED | $31.38 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142309427 | ABIOMED | $41.57 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142309429 | ABIOMED | $37.49 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142309431 | ABIOMED | $110.47 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142309433 | ABIOMED | $116.16 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150682745 | Aurinia Pharma U.S., Inc. | $16.34 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.